{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:03:11Z","timestamp":1784728991861,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1D1A1B04934590"],"award-info":[{"award-number":["2016R1D1A1B04934590"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["H I17C0912"],"award-info":[{"award-number":["H I17C0912"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00535-019-01628-z","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T17:03:41Z","timestamp":1568826221000},"page":"330-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis"],"prefix":"10.1007","volume":"55","clinical-trial-number":[{"clinical-trial-number":"nct02206841","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1919-6800","authenticated-orcid":false,"given":"Donghee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-1007","authenticated-orcid":false,"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae Kyung","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"1628_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"1628_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1628_CR3","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","volume":"57","author":"D Kim","year":"2013","unstructured":"Kim D, Kim WR, Kim HJ, et al. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013;57:1357\u201365.","journal-title":"Hepatology"},{"key":"1628_CR4","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jval.2016.02.008","volume":"19","author":"DD Kim","year":"2016","unstructured":"Kim DD, Basu A. Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis. Value Health. 2016;19:602\u201313.","journal-title":"Value Health"},{"key":"1628_CR5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1096\/fj.14-263913","volume":"29","author":"F Badoud","year":"2015","unstructured":"Badoud F, Perreault M, Zulyniak MA, et al. Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J. 2015;29:748\u201358.","journal-title":"FASEB J"},{"key":"1628_CR6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","volume":"1","author":"N Stefan","year":"2013","unstructured":"Stefan N, Haring HU, Hu FB, et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1628_CR7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","volume":"26","author":"N Stefan","year":"2017","unstructured":"Stefan N, Schick F, Haring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26:292\u2013300.","journal-title":"Cell Metab"},{"key":"1628_CR8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","volume":"168","author":"RP Wildman","year":"2008","unstructured":"Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999\u20132004). Arch Intern Med. 2008;168:1617\u201324.","journal-title":"Arch Intern Med"},{"key":"1628_CR9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","volume":"159","author":"CK Kramer","year":"2013","unstructured":"Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159:758\u201369.","journal-title":"Ann Intern Med"},{"key":"1628_CR10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","volume":"66","author":"BK Koo","year":"2017","unstructured":"Koo BK, Kim D, Joo SK, et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66:123\u201331.","journal-title":"J Hepatol"},{"issue":"123\u201331","key":"1628_CR11","first-page":"e1","volume":"16","author":"D Kim","year":"2018","unstructured":"Kim D, Kim W, Joo SK, et al. Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis. Clin Gastroenterol Hepatol. 2018;16(123\u201331):e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1628_CR12","unstructured":"Obesity: preventing and managing the global epidemic. In: Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1\u2013253."},{"key":"1628_CR13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jhep.2011.03.030","volume":"55","author":"S Mauss","year":"2011","unstructured":"Mauss S, Berger F, Filmann N, et al. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B. J Hepatol. 2011;55:1235\u201340.","journal-title":"J Hepatol"},{"key":"1628_CR14","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640\u20135.","journal-title":"Circulation"},{"key":"1628_CR15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/M16-1895","volume":"166","author":"UP Gujral","year":"2017","unstructured":"Gujral UP, Vittinghoff E, Mongraw-Chaffin M, et al. Cardiometabolic abnormalities among normal-weight persons from five racial\/ethnic groups in the united states: a cross-sectional analysis of two cohort studies. Ann Intern Med. 2017;166:628\u201336.","journal-title":"Ann Intern Med"},{"key":"1628_CR16","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1210\/jc.2013-4427","volume":"99","author":"Y Heianza","year":"2014","unstructured":"Heianza Y, Arase Y, Tsuji H, et al. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20). J Clin Endocrinol Metab. 2014;99:2952\u201360.","journal-title":"J Clin Endocrinol Metab"},{"key":"1628_CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12020-017-1313-6","volume":"57","author":"Y Hashimoto","year":"2017","unstructured":"Hashimoto Y, Hamaguchi M, Fukuda T, et al. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. Endocrine. 2017;57:89\u201397.","journal-title":"Endocrine"},{"key":"1628_CR18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/aje\/kwx267","volume":"187","author":"M Gasull","year":"2018","unstructured":"Gasull M, Castell C, Pallares N, et al. Blood concentrations of persistent organic pollutants and unhealthy metabolic phenotypes in normal-weight, overweight, and obese individuals. Am J Epidemiol. 2018;187:494\u2013506.","journal-title":"Am J Epidemiol"},{"key":"1628_CR19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/ijo.2015.151","volume":"40","author":"R Dobson","year":"2016","unstructured":"Dobson R, Burgess MI, Sprung VS, et al. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int J Obes (Lond). 2016;40:153\u201361.","journal-title":"Int J Obes (Lond)"},{"key":"1628_CR20","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467\u201374.","journal-title":"Am J Gastroenterol"},{"key":"1628_CR21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011;53:810\u201320.","journal-title":"Hepatology"},{"key":"1628_CR22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"1628_CR23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.25593","volume":"56","author":"D Kim","year":"2012","unstructured":"Kim D, Choi SY, Park EH, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012;56:605\u201313.","journal-title":"Hepatology"},{"key":"1628_CR24","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc10-0606","volume":"33","author":"JY Yim","year":"2010","unstructured":"Yim JY, Kim D, Lim SH, et al. Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care. 2010;33:2665\u2013700.","journal-title":"Diabetes Care"},{"key":"1628_CR25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/jgh.14056","volume":"33","author":"BK Koo","year":"2018","unstructured":"Koo BK, Joo SK, Kim D, et al. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2018;33:1277\u201385.","journal-title":"J Gastroenterol Hepatol"},{"key":"1628_CR26","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40:1461\u20135.","journal-title":"Nat Genet"},{"key":"1628_CR27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","volume":"46","author":"J Kozlitina","year":"2014","unstructured":"Kozlitina J, Smagris E, Stender S, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014;46:352\u20136.","journal-title":"Nat Genet"},{"key":"1628_CR28","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/db12-0858","volume":"62","author":"G Musso","year":"2013","unstructured":"Musso G, Cassader M, Bo S, et al. Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism. Diabetes. 2013;62:1109\u201320.","journal-title":"Diabetes"},{"issue":"1219\u201330","key":"1628_CR29","first-page":"e6","volume":"150","author":"RM Mancina","year":"2016","unstructured":"Mancina RM, Dongiovanni P, Petta S, et al. The MBOAT7-TMC4 Variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of european descent. Gastroenterology. 2016;150(1219\u201330):e6.","journal-title":"Gastroenterology"},{"key":"1628_CR30","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1210\/jc.2004-0165","volume":"89","author":"AD Karelis","year":"2004","unstructured":"Karelis AD, St-Pierre DH, Conus F, et al. Metabolic and body composition factors in subgroups of obesity: what do we know? The Journal of clinical endocrinology and metabolism. 2004;89:2569\u201375.","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"1628_CR31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","volume":"15","author":"D Kim","year":"2017","unstructured":"Kim D, Kim WR. Nonobese fatty liver disease. Clin Gastroenterol Hepatol. 2017;15:474\u201385.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1628_CR32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/oby.21443","volume":"24","author":"D Hojland Ipsen","year":"2016","unstructured":"Hojland Ipsen D, Tveden-Nyborg P, Lykkesfeldt J. Normal weight dyslipidemia: is it all about the liver? Obesity (Silver Spring). 2016;24:556\u201367.","journal-title":"Obesity (Silver Spring)"},{"issue":"635\u201348","key":"1628_CR33","first-page":"e14","volume":"149","author":"J du Plessis","year":"2015","unstructured":"du Plessis J, van Pelt J, Korf H, et al. Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease. Gastroenterology. 2015;149(635\u201348):e14.","journal-title":"Gastroenterology"},{"key":"1628_CR34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/db09-0942","volume":"59","author":"E Arner","year":"2010","unstructured":"Arner E, Westermark PO, Spalding KL, et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes. 2010;59:105\u20139.","journal-title":"Diabetes"},{"key":"1628_CR35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/nu8060320","volume":"8","author":"A Munoz-Garach","year":"2016","unstructured":"Munoz-Garach A, Cornejo-Pareja I, Tinahones FJ. Does metabolically healthy obesity exist? Nutrients. 2016;8:320.","journal-title":"Nutrients"},{"issue":"1","key":"1628_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.metabol.2015.10.019","volume":"65","author":"H Mathew","year":"2016","unstructured":"Mathew H, Farr OM, Mantzoros CS. Metabolic health and weight: understanding metabolically unhealthy normal weight or metabolically healthy obese patients. Metabolism. 2016;65(1):73\u201380. https:\/\/doi.org\/10.1016\/j.metabol.2015.10.019","journal-title":"Metabolism."},{"key":"1628_CR37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/nyas.13230","volume":"1391","author":"CM Phillips","year":"2017","unstructured":"Phillips CM. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann N Y Acad Sci. 2017;1391:85\u2013100.","journal-title":"Ann N Y Acad Sci"},{"key":"1628_CR38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.28697","volume":"65","author":"JC Leung","year":"2017","unstructured":"Leung JC, Loong TC, Wei JL, et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology. 2017;65:54\u201364.","journal-title":"Hepatology"},{"key":"1628_CR39","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2018.02.055","volume":"71","author":"M Mongraw-Chaffin","year":"2018","unstructured":"Mongraw-Chaffin M, Foster MC, Anderson CAM, et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2018;71:1857\u201365.","journal-title":"J Am Coll Cardiol"},{"key":"1628_CR40","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.ijcard.2013.07.230","volume":"168","author":"J Fan","year":"2013","unstructured":"Fan J, Song Y, Chen Y, et al. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol. 2013;168:4761\u20138.","journal-title":"Int J Cardiol"},{"key":"1628_CR41","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J, et al. The metabolic syndrome\u2014a new worldwide definition. Lancet. 2005;366:1059\u201362.","journal-title":"Lancet"},{"key":"1628_CR42","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","volume":"22","author":"GC Farrell","year":"2007","unstructured":"Farrell GC, Chitturi S, Lau GK, et al. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007;22:775\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"1628_CR43","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep.25539","volume":"55","author":"R Lomonaco","year":"2012","unstructured":"Lomonaco R, Ortiz-Lopez C, Orsak B, et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology. 2012;55:1389\u201397.","journal-title":"Hepatology"},{"issue":"3","key":"1628_CR44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2213-8587(17)30292-9","volume":"6","author":"N Stefan","year":"2018","unstructured":"Stefan N, Haring HU, Schulze MB. Metabolically healthy obesity: the low-hanging fruit in obesity treatment? Lancet Diabetes Endocrinol. 2018;6(3):249\u201358.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1628_CR45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2016.318","volume":"112","author":"A Feldman","year":"2017","unstructured":"Feldman A, Eder SK, Felder TK, et al. Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver. Am J Gastroenterol. 2017;112:102\u201310.","journal-title":"Am J Gastroenterol"},{"key":"1628_CR46","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/apt.12609","volume":"39","author":"J Shen","year":"2014","unstructured":"Shen J, Wong GL, Chan HL, et al. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome. Aliment Pharmacol Ther. 2014;39:532\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1628_CR47","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ajg.2015.235","volume":"110","author":"JL Wei","year":"2015","unstructured":"Wei JL, Leung JC, Loong TC, et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy. Am J Gastroenterol. 2015;110:1306\u201314 (quiz 15).","journal-title":"Am J Gastroenterol."},{"key":"1628_CR48","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.28142","volume":"62","author":"CJ Pirola","year":"2015","unstructured":"Pirola CJ, Sookoian S. The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: a meta-analysis. Hepatology. 2015;62:1742\u201356.","journal-title":"Hepatology"},{"key":"1628_CR49","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/hepr.12648","volume":"46","author":"Y Honda","year":"2016","unstructured":"Honda Y, Yoneda M, Kessoku T, et al. Characteristics of non-obese non-alcoholic fatty liver disease: effect of genetic and environmental factors. Hepatol Res. 2016;46:1011\u20138.","journal-title":"Hepatol Res"},{"key":"1628_CR50","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00394-013-0635-2","volume":"53","author":"H Schroder","year":"2014","unstructured":"Schroder H, Ramos R, Baena-Diez JM, et al. Determinants of the transition from a cardiometabolic normal to abnormal overweight\/obese phenotype in a Spanish population. Eur J Nutr. 2014;53:1345\u201353.","journal-title":"Eur J Nutr"},{"key":"1628_CR51","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67:862\u201373.","journal-title":"J Hepatol"},{"key":"1628_CR52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHOE Consultation","year":"2004","unstructured":"Consultation WHOE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157\u201363.","journal-title":"Lancet"},{"key":"1628_CR53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1010679","volume":"364","author":"W Zheng","year":"2011","unstructured":"Zheng W, McLerran DF, Rolland B, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011;364:719\u201329.","journal-title":"N Engl J Med"},{"key":"1628_CR54","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00535-017-1372-8","volume":"53","author":"Y Seko","year":"2018","unstructured":"Seko Y, Yamaguchi K, Mizuno N, et al. Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease. J Gastroenterol. 2018;53:438\u201348.","journal-title":"J Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-019-01628-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-019-01628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T10:24:34Z","timestamp":1628591074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-019-01628-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1628"],"URL":"https:\/\/doi.org\/10.1007\/s00535-019-01628-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}